NCT04645914

Brief Summary

The survey participants are divided into a smoking and non-smoking group. The smoker group is further divided according to the quantity and quality of nicotine ("normal" smoking, vaping). After reaching a steady state, the cutaneous blood flow at rest in the extremities of all participants is determined by Laser Doppler Imaging as a reference value. Laser Doppler Imaging produces images of the blood flow using perfusion units (PU). Subsequently, the perfusion is measured again after smoking/vaping. The difference in skin perfusion of the extremities is calculated (δ-Perfusion). All measurements are performed under controlled vital parameters (body temperature, systolic and diastolic blood pressure, heart rate) and controlled room temperature as well as 15-minute acclimatization of the patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
198

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 2, 2020

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

November 15, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 27, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

November 27, 2020

Status Verified

November 1, 2020

Enrollment Period

1.9 years

First QC Date

November 15, 2020

Last Update Submit

November 22, 2020

Conditions

Keywords

PerfusionLaser Speckle Contrast AnalysisLaser Doppler CameraNicotineSmokingVaping

Outcome Measures

Primary Outcomes (2)

  • Perfusion of the extremities for non-smokers, smokers and vapers

    The perfusion of the extremities will be measured in Perfusion Units. The Perfusion Units are calculated directly through the Laser Doppler Camera as a result of the examination.

    30 seconds

  • Difference of perfusion after smoking/vaping

    The perfusion of the extremities will be measured after the consume of cigarettes/electronic cigarettes in Perfusion Units. The difference between the results of the examination before and after the consume of cigarettes/electronic cigarettes will be measured in Perfusion Units.

    30 seconds

Secondary Outcomes (3)

  • Correlation of perfusion with age

    30 seconds

  • Correlation of perfusion with gender

    30 seconds

  • Correlation of perfusion with quantity of smoking/vaping

    30 seconds

Study Arms (2)

No smokers

NO INTERVENTION

Healthy subjects who do not consume any nicotine products

Smokers/Vapers

EXPERIMENTAL

Healthy subjects who consume nicotine products

Behavioral: Use of nicotine product (smoking/vaping)

Interventions

The smokers/vapers are consuming during the study one nicotine product of their own. The dose is the same as each individual is consuming regularly

Smokers/Vapers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy adult non-smokers, smokers, vapers

You may not qualify if:

  • Adults with cardiopulmonary diseases
  • Pregnant women
  • Adults that participating in other surveys

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Muenster

Münster, North Rhine-Westphalia, 48149, Germany

RECRUITING

MeSH Terms

Conditions

Tobacco Use DisorderVapingSmoking

Interventions

Smoking DevicesElectronic Nicotine Delivery Systems

Condition Hierarchy (Ancestors)

Substance-Related DisordersChemically-Induced DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Manufactured MaterialsTechnology, Industry, and Agriculture

Study Officials

  • Andreas Kyriakou, MD

    University Hospital Muenster

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Andreas Kyriakou, MD

CONTACT

Alexander Oberhuber, Univ.-Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Double blind through randomization
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Two groups : consumers of cigarettes/e-cigarettes and non consumers of cigarettes/e-cigarettes
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vacular Surgery Resident

Study Record Dates

First Submitted

November 15, 2020

First Posted

November 27, 2020

Study Start

July 2, 2020

Primary Completion

May 30, 2022

Study Completion

December 1, 2022

Last Updated

November 27, 2020

Record last verified: 2020-11

Data Sharing

IPD Sharing
Will not share

Locations